Header Logo

Connection

JENNIFER FOSTER to Topotecan

Back to Details
This is a "connection" page, showing publications JENNIFER FOSTER has written about Topotecan.
JENNIFER FOSTER
Connection Strength
0.060
Topotecan
  1. A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma. Cancer. 2025 Feb 15; 131(4):e35751.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.